Try our Advanced Search for more refined results
March 04, 2022
Novo Nordisk Inc. et al v. Rio Biopharmaceuticals, Inc. et al
Case Number:
1:22-cv-00294
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
- Alvogen Group Inc.
- Dr. Reddy's Laboratories Ltd.
- Novo Nordisk A S
- Sun Pharmaceutical Industries Ltd.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 09, 2022
Viatris Can't Keep Novo's Weight Loss Drug IP Suit In W.Va.
The U.S. Judicial Panel on Multidistrict Litigation has rejected Viatris' calls to have Novo Nordisk's drug patent suit against it over diabetes drug Ozempic stay in West Virginia federal court, centralizing the case with five related suits lodged against drugmakers like Dr. Reddy's in Delaware.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login